Overview
Lakshmi Nayak is an Oncologist and a Neurologist in Boston, Massachusetts. Dr. Nayak is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. Her top areas of expertise are Astrocytoma, Glioma, Glioblastoma, and Brain Tumor. Dr. Nayak is currently accepting new patients.
Her clinical research consists of co-authoring 110 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
450 Brookline Ave, Boston, MA 02215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Rhode Island Hospital
Heinrich Elinzano is a Neurologist in Providence, Rhode Island. Dr. Elinzano is rated as a Distinguished provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Subependymoma, Brain Stem Cancer, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET).
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc
Erik Uhlmann is a Neurologist in Boston, Massachusetts. Dr. Uhlmann is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Metastatic Brain Tumor, Brain Tumor, Astrocytoma, Glioblastoma, and Gamma Knife Radiosurgery.
Dana-Farber Cancer Institute, Inc.
David Reardon is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Reardon is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Tissue Biopsy. Dr. Reardon is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AstrocytomaDr. Nayak isElite. Learn about Astrocytoma.
- Brain TumorDr. Nayak isElite. Learn about Brain Tumor.
- GlioblastomaDr. Nayak isElite. Learn about Glioblastoma.
- GliomaDr. Nayak isElite. Learn about Glioma.
- Distinguished
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Nayak isDistinguished. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Embryonal Tumor with Multilayered Rosettes
- EpendymomaDr. Nayak isDistinguished. Learn about Ependymoma.
- Gliomatosis CerebriDr. Nayak isDistinguished. Learn about Gliomatosis Cerebri.
- GliosarcomaDr. Nayak isDistinguished. Learn about Gliosarcoma.
- Metastatic Brain TumorDr. Nayak isDistinguished. Learn about Metastatic Brain Tumor.
- Advanced
- Gastric LymphomaDr. Nayak isAdvanced. Learn about Gastric Lymphoma.
- MeningiomaDr. Nayak isAdvanced. Learn about Meningioma.
- Experienced
- Acute Myeloid Leukemia (AML)Dr. Nayak isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Nayak isExperienced. Learn about Agranulocytosis.
- B-Cell LymphomaDr. Nayak isExperienced. Learn about B-Cell Lymphoma.
- Brain Stem CancerDr. Nayak isExperienced. Learn about Brain Stem Cancer.
- Breast CancerDr. Nayak isExperienced. Learn about Breast Cancer.
- Burkitt LymphomaDr. Nayak isExperienced. Learn about Burkitt Lymphoma.